BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35191735)

  • 1. Safety and Diagnostic Yield of
    Kumar R; Singh SK; Mittal BR; Vadi SK; Kakkar N; Singh H; Krishnaraju VS; Kumar S; Bhattacharya A
    Radiology; 2022 May; 303(2):392-398. PubMed ID: 35191735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Evaluation of
    Lopci E; Lughezzani G; Castello A; Saita A; Colombo P; Hurle R; Peschechera R; Benetti A; Zandegiacomo S; Pasini L; Casale P; Pietro D; Bevilacqua G; Balzarini L; Buffi NM; Guazzoni G; Lazzeri M
    Eur Urol Focus; 2021 Jul; 7(4):764-771. PubMed ID: 32312701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zhang LL; Li WC; Xu Z; Jiang N; Zang SM; Xu LW; Huang WB; Wang F; Sun HB
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):483-492. PubMed ID: 32734457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm.
    Kumar R; Mittal BR; Bhattacharya A; Vadi SK; Singh H; Bal A; Shukla J; Singh H; Sharma V; Sood A; Singh SK
    Diagn Interv Imaging; 2020 Mar; 101(3):157-167. PubMed ID: 31722844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of
    Ferraro DA; Becker AS; Kranzbühler B; Mebert I; Baltensperger A; Zeimpekis KG; Grünig H; Messerli M; Rupp NJ; Rueschoff JH; Mortezavi A; Donati OF; Sapienza MT; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3315-3324. PubMed ID: 33620559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer.
    Lopci E; Lughezzani G; Castello A; Colombo P; Casale P; Saita A; Buffi NM; Guazzoni G; Chiti A; Lazzeri M
    Clin Transl Oncol; 2021 Jan; 23(1):172-178. PubMed ID: 32447644
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Liu C; Liu T; Zhang Z; Zhang N; Du P; Yang Y; Liu Y; Yu W; Li N; Gorin MA; Rowe SP; Zhu H; Yan K; Yang Z
    J Nucl Med; 2020 Sep; 61(9):1314-1319. PubMed ID: 32034111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and prospective validation of an SUV
    Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W
    Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749
    [No Abstract]   [Full Text] [Related]  

  • 10. How accurate is
    Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
    Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PRIMARY Score: Using Intraprostatic
    Emmett L; Papa N; Buteau J; Ho B; Liu V; Roberts M; Thompson J; Moon D; Sheehan-Dare G; Alghazo O; Agrawal S; Murphy D; Stricker P; Hope TA; Hofman MS
    J Nucl Med; 2022 Nov; 63(11):1644-1650. PubMed ID: 35301240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
    Bodar YJL; Boevé LMS; van Leeuwen PJ; Baars PC; Nieuwenhuijzen JA; van Haarst EP; Oddens JR; Donswijk ML; van Riel LAMJG; Scheltema MJ; Meijer D; Hendrikse NH; Oprea-Lager DE; Vis AN
    BJU Int; 2023 Dec; 132(6):705-712. PubMed ID: 37620288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of the diagnostic utility of
    Vlachostergios PJ; Niaz MJ; Thomas C; Christos PJ; Osborne JR; Margolis DJA; Khani F; Bander NH; Scherr DS; Tagawa ST
    Prostate; 2022 Mar; 82(4):483-492. PubMed ID: 34985786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT).
    Heetman JG; Lavalaye J; Polm PD; Soeterik TFW; Wever L; Paulino Pereira LJ; van der Hoeven EJRJ; van Melick HHE; van den Bergh RCN
    Eur Urol Oncol; 2024 Apr; 7(2):204-210. PubMed ID: 37296065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.
    Emmett L; Buteau J; Papa N; Moon D; Thompson J; Roberts MJ; Rasiah K; Pattison DA; Yaxley J; Thomas P; Hutton AC; Agrawal S; Amin A; Blazevski A; Chalasani V; Ho B; Nguyen A; Liu V; Lee J; Sheehan-Dare G; Kooner R; Coughlin G; Chan L; Cusick T; Namdarian B; Kapoor J; Alghazo O; Woo HH; Lawrentschuk N; Murphy D; Hofman MS; Stricker P
    Eur Urol; 2021 Dec; 80(6):682-689. PubMed ID: 34465492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX).
    Lopci E; Lazzeri M; Colombo P; Casale P; Buffi NM; Saita A; Peschechera R; Hurle R; Marzo K; Leonardi L; Morenghi E; Balzarini L; Disconzi L; Guazzoni G; Chiti A; Lughezzani G
    Urol Int; 2023; 107(5):433-439. PubMed ID: 36724746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of whole-body MRI and
    Sawicki LM; Kirchner J; Buddensieck C; Antke C; Ullrich T; Schimmöller L; Boos J; Schleich C; Schaarschmidt BM; Buchbender C; Heusch P; Rabenalt R; Albers P; Antoch G; Müller HW; Hautzel H
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1542-1550. PubMed ID: 30879122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hot needles can confirm accurate lesion sampling intraoperatively using [
    Ferraro DA; Laudicella R; Zeimpekis K; Mebert I; Müller J; Maurer A; Grünig H; Donati O; Sapienza MT; Rueschoff JH; Rupp N; Eberli D; Burger IA
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1721-1730. PubMed ID: 34725726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection Rate of
    Pepe P; Pepe L; Cosentino S; Ippolito M; Pennisi M; Fraggetta F
    Anticancer Res; 2022 Jun; 42(6):3011-3015. PubMed ID: 35641295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Biopsy in Men High Risk for Prostate Cancer:
    Pepe P; Pennisi M
    Clin Genitourin Cancer; 2023 Dec; 21(6):639-642. PubMed ID: 37394379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.